Design Day 2009: The results are in!
Design Day 2009 presented remarkable student design work. Here are the prize-winning projects.
First Place
SutureCell™: Stem Cell Delivery Suture
Sponsor: Rick Spedden, Laura Pingel, and Lew Schon, MD – Bioactive Surgical, Inc.
Team Members: Matt Rubashkin, David Attarzadeh, Raghav Badrinath, Kristie
Charoen, Stephanie D’Souza, Hayley Osen, Frank Qin, Avik Som, Steven Su,
Lawrence Wei
Tendon, muscle and ligament repair surgeries are accompanied by poor tissue regeneration and long recovery times. To improve tissue regeneration and reduce injury recurrence, the team developed SutureCell™, a surgical suture that
serves as a textile scaffold for mesenchymal stem cell (MSC) delivery of pro-fibrotic and anti-inflammatory cytokines by the MSCs at the site of injury.
Second Place
Stem Cell Immobilization for Orthopedic Implantation
Sponsor: Rick Spedden, Laura Pingel, and Lew Schon, MD – Bioactive Surgical, Inc.
Team Members: Judy Qui, Peter Stempniewicz, Dan Young, Bill Borch, Forum
Shah, Srikanth Divi, Chen Chen, Tony Chang, Jesse Hamilton, and Noah Young
Mesenchymal stem cells (MSCs) retained at the site of orthopedic implantation have shown success in facilitating tissue regeneration and reducing healing time.
The team developed an active, MSC-selective thin film that directly coats implants. The goal is to simultaneously isolate, concentrate, and immobilize MSCs onto orthopedic implants.
Third Place
Improving Laparoscopic Partial Nephrectomy (LPN)
Sponsor: Rob Caruso, M.D., Urologist, Essex-Hudson Urology and Clinical
Assistant Professor of Surgery, UMDNJ-New Jersey Medical School, and
Malcolm Lloyd, M.D., Founder, Device Evolutions LLC
Team Members: Francisco Contijoch, Aubri Gillespie, Carolyn Purington, Michelle Harran, Smita Mohan, Tom Chen, Rohan Shah, Kaori Yamada, and Philip Parker
The only accepted, effective treatment for renal cell carcinoma is surgical removal of the affected kidney area.
The Laparoscopic Partial Nephrectomy (LPN) is a minimally invasive procedure which removes only the area of the kidney containing the tumor.
To improve the quality and effectiveness of LPN, the team designed a device which addresses the difficult elements of the procedure which hinder its widespread use.